cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Point Biopharma Global Inc
2 watching
Current Price
$7.38
$0.16
(2.22%)
logo-pnt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
767.93M
52-Week High
52-Week High
10.98
52-Week Low
52-Week Low
5.225
Average Volume
Average Volume
0.48M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization767.93M
icon52-Week High10.98
icon52-Week Low5.225
iconAverage Volume0.48M
iconDividend Yield--
iconP/E Ratio--
What does the Point Biopharma Global Inc do?
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate cancer; and PNT2003, a somatostatin-targeted radioligand, which is in Phase III trial for the treatment of neuroendocrine tumors. The company is also developing PNT2001, a next-generation PSMA-targeting product candidate for the treatment of non-metastatic castration sensitive prostate cancer, which is under preclinical studies; and PNT-2004, a fibroblast activation protein-a targeting program being developed for use in multiple tumor types that is under preclinical studies. In addition, it has product candidates being developed on CanSEEK technology sub-licensed from both Bach Biosciences LLC and Avacta Life Sciences Limited. POINT Biopharma Global Inc. was founded in 2019 and is headquartered in Indianapolis, Indiana.
Read More
How much money does Point Biopharma Global Inc make?
News & Events about Point Biopharma Global Inc.
Globe Newswire
17days ago
Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidanceINDIANAPOLIS, Jan. 12, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the Company or POINT), a company accelerating the discovery, development, and global access to life-...
Globe Newswire
1month ago
INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance...
Globe Newswire
3 months ago
PNT2001 displays enhanced internalization, biodistribution, and pre-clinical efficacy in multiple tumor models, making it a prime candidate for the delivery of actinium-225 Targeting IND/CTA submission for PNT2001 program in H1 2023 INDIANAPOLIS, Oct. 17, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma ...
Globe Newswire
4 months ago
INDIANAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the Company or POINT), a company accelerating the discovery, development and global access to life-changing radiopharmaceuticals, today announced the pricing of its public offering of 13,900,000 shares of ...
Globe Newswire
4 months ago
Newly published poster on the single-arm 27-patient safety and dosimetry lead-in provides key updates including: A median rPFS time of 11.5 months A best radiographic objective response (CR, PR) was achieved in 60% of the 10 participants with evaluable disease at baseline PNT2002 was well tolerated ...
Frequently Asked Questions
Frequently Asked Questions
What is Point Biopharma Global Inc share price today?
plus_minus_icon
Can Indians buy Point Biopharma Global Inc shares?
plus_minus_icon
How can I buy Point Biopharma Global Inc shares from India?
plus_minus_icon
Can Fractional shares of Point Biopharma Global Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Point Biopharma Global Inc stocks?
plus_minus_icon
What is today’s traded volume of Point Biopharma Global Inc?
plus_minus_icon
What is today’s market capitalisation of Point Biopharma Global Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Point Biopharma Global Inc?
plus_minus_icon
What percentage is Point Biopharma Global Inc down from its 52-Week High?
plus_minus_icon
What percentage is Point Biopharma Global Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.38
$0.16
(2.22%)
logo-pnt
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00